Summary:
This podcast features a panel discussion from the 2023 PODD: Partnership Opportunities in Drug Delivery Conference on delivery challenges from the oncology pipeline including intramodality competition between monoclonal antibodies, bispecifics, ADCs, CARs and other cell therapies; negotiating the tradeoffs between therapeutic efficacy, regimen simplicity, and technical complexity; and impacts of different modalities on stakeholders from manufacturing to HCPs and patients.
To learn more about the PODD conference, please visit PODDConference.com.
Speakers
Darren Reid, PhD
Director, Process Development
Amgen
Ronak Salva, PharmD, PhD, MBA
Director, Strategic Ventures
Catalent Pharma Solutions
Theresa Scheuble
Head, Enterprise Design & Innovation
Johnson and Johnson
Shankar Swaminathan, PhD
Team Lead, Drug Product Development, Astellas Institute for Regenerative Medicine
Astellas Pharma
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.